{
    "clinical_study": {
        "@rank": "45124", 
        "acronym": "SME", 
        "arm_group": {
            "arm_group_label": "Patients with Medtronic neurostimulator", 
            "description": "Patients suffering from chronic neuropathic pain syndrome implanted (first implant or replacements) with a Medtronic neurostimulator."
        }, 
        "brief_summary": {
            "textblock": "Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over\n      2 years following SCS implant.\n\n      This study is requested by French Health Authorities for reimbursement renewal, to maintain\n      reimbursement for SCS in approved indication in France."
        }, 
        "brief_title": "Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Pain Syndrome", 
        "condition_browse": {
            "mesh_term": "Somatoform Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient indicated for Spinal Cord Stimulation (pain therapy)\n\n          -  Patient implanted for less than 3 months or hospitalized for the implant of a\n             Medtronic neurostimulator including:\n\n          -  primary implant with Spinal Cord Stimulation indication and positive   test of\n             stimulation or\n\n          -  device replacement of a Medtronic neurostimulator used for Pain Therapy\n\n          -  Evaluation of usual pain in the back, upper and lower limbs using a visual analogic\n             scale must be available  for the 3 days preceding implant.\n\n          -  Treatments must also be available\n\n          -  Patient read and signed the data release form\n\n        Exclusion Criteria:\n\n          -  Patient declined participation\n\n          -  Patient is not available for follow up\n\n          -  Stimulation of other body part than spinal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients implanted (first implant or replacements) with a Medtronic neurostimulator in\n        selected French sites ."
            }
        }, 
        "enrollment": {
            "#text": "418", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778426", 
            "org_study_id": "1051"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic neuropathic pain syndrome", 
            "Spinal Cord Stimulation", 
            "Painstim devices", 
            "Efficacy", 
            "Safety"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75014"
                }, 
                "name": "H\u00f4pital Saint Anne - 1 rue Cabanis"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy", 
        "overall_official": {
            "affiliation": "H\u00f4pital Saint Anne Paris", 
            "last_name": "Marie-Christine DJIAN, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "France: The Commission nationale de l\u2019informatique et des libert\u00e9s", 
                "France: Haute Autorit\u00e9 de Sant\u00e9 Transparency Commission", 
                "France: Conseil National de l'Ordre des M\u00e9decins"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the percentage of patients with 50% decrease in the VAS (Visual Analogic Scale) score over 2 years following SCS implant in first implant patients", 
            "measure": "PainStim Efficacy", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778426"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Report all adverse device effects and procedure related adverse events over 2 years following SCS implant.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "March 2014"
    }
}